Kaixian Chen mostly deals with Stereochemistry, Biochemistry, Protein structure, Binding site and Organic chemistry. Kaixian Chen combines topics linked to Rational design with his work on Stereochemistry. His Protein structure research is multidisciplinary, incorporating elements of Crystallography, Molecular biology, Peptide sequence and Dimer.
His work carried out in the field of Binding site brings together such families of science as Active site, Plasma protein binding, Hydrogen bond and Molecular dynamics. In the subject of general Organic chemistry, his work in Galactoside, Aryl, Catalysis and Corrosion is often linked to Glucoside, thereby combining diverse domains of study. His Docking research integrates issues from Computational biology, DOCK and Dissociation constant.
Stereochemistry, Biochemistry, Binding site, Molecular model and Combinatorial chemistry are his primary areas of study. His Stereochemistry study combines topics in areas such as Structure–activity relationship and Hydrogen bond. His Biochemistry study is mostly concerned with Enzyme, IC50, In vitro and Plasma protein binding.
Binding site connects with themes related to Protein structure in his study. His work deals with themes such as Crystallography and Biophysics, which intersect with Protein structure. His Combinatorial chemistry research focuses on subjects like Catalysis, which are linked to Aryl.
Kaixian Chen mainly focuses on Artificial intelligence, Biochemistry, Machine learning, Drug discovery and IC50. In general Artificial intelligence, his work in Deep learning is often linked to Value, Block and Protocol linking many areas of study. His work in Biochemistry is not limited to one particular discipline; it also encompasses Anti-inflammatory.
His research investigates the connection between Machine learning and topics such as Kinome that intersect with issues in Polypharmacology and In silico. The concepts of his Drug discovery study are interwoven with issues in Self attention, Peptide sequence, Chemical synthesis and Computational biology. His Nuclear receptor research is multidisciplinary, incorporating perspectives in Virtual screening and Small molecule.
Kaixian Chen mainly investigates Artificial intelligence, Machine learning, Drug discovery, Deep learning and Stereochemistry. His Artificial intelligence study also includes fields such as
While the research belongs to areas of Drug discovery, Kaixian Chen spends his time largely on the problem of Chemical biology, intersecting his research to questions surrounding Allosteric regulation, Biophysics, Enzyme catalysis, Molecular dynamics and Transferase. His study in Deep learning is interdisciplinary in nature, drawing from both Artificial neural network and Atom. His Stereochemistry research is multidisciplinary, incorporating elements of Protein arginine methyltransferase 5, Ic50 values and Amide.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Predicting protein-protein interactions based only on sequences information.
Juwen Shen;Jian Zhang;Xiaomin Luo;Weiliang Zhu.
Proceedings of the National Academy of Sciences of the United States of America (2007)
TarFisDock: a web server for identifying drug targets with docking approach
Honglin Li;Zhenting Gao;Ling Kang;Hailei Zhang.
Nucleic Acids Research (2006)
PDTD: a web-accessible protein database for drug target identification
Zhenting Gao;Zhenting Gao;Honglin Li;Honglin Li;Hailei Zhang;Xiaofeng Liu.
BMC Bioinformatics (2008)
Conformational transition of amyloid β-peptide
Yechun Xu;Jianhua Shen;Xiaomin Luo;Weiliang Zhu.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Halogen bond: its role beyond drug-target binding affinity for drug discovery and development.
Zhijian Xu;Zhuo Yang;Yingtao Liu;Yunxiang Lu.
Journal of Chemical Information and Modeling (2014)
A Series of α-Heterocyclic Carboxaldehyde Thiosemicarbazones Inhibit Topoisomerase IIα Catalytic Activity
He Huang;Qin Chen;Xin Ku;Linghua Meng.
Journal of Medicinal Chemistry (2010)
Cinanserin Is an Inhibitor of the 3C-Like Proteinase of Severe Acute Respiratory Syndrome Coronavirus and Strongly Reduces Virus Replication In Vitro
Lili Chen;Chunshan Gui;Xiaomin Luo;Qingang Yang.
Journal of Virology (2005)
Virtual Screening on Natural Products for Discovering Active Compounds and Target Information
Jianhua Shen;Xiaoying Xu;Feng Cheng;Hong Liu.
Current Medicinal Chemistry (2003)
A Simple and Convenient Copper-Catalyzed Tandem Synthesis of Quinoline-2-carboxylates at Room Temperature
He Huang;Hualiang Jiang;Kaixian Chen;Hong Liu.
Journal of Organic Chemistry (2009)
pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses.
Jinzhi Tan;Koen H.G. Verschueren;Kanchan Anand;Jianhua Shen.
Journal of Molecular Biology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Chinese Academy of Sciences
Chinese Academy of Sciences
Shandong University
Nanjing University of Chinese Medicine
Chinese Academy of Sciences
UCB Pharma (Belgium)
Pennsylvania State University
Nanyang Technological University
Chinese Academy of Sciences
Nanjing University
Stanford University
University of Chicago
King's College London
Royal Institute of Technology
Spanish National Research Council
Fuzhou University
University of Tasmania
University of Florida
University of Georgia
Universität Hamburg
University of California, Los Angeles
University of Geneva
Catholic University of America
University of California, San Diego
Rutgers, The State University of New Jersey
University of British Columbia